Geographic atrophy

Thin Double Layer Sign in the Fovea on OCT Predicts GA

Structural imaging shows the presence of biomarkers associated with the development of foveal atrophy at two years.

AMD Genetic Profile Predictive of Early GA Enlargement

ARMS2/HTRA1 is an important risk factor for identifying eyes likely to experience fast lesion progression.

New GA Drug from Iveric Bio Approved

Clinical trials show Izervay can slow disease progression with as few as six monthly doses.

Novel Microperimetry Endpoints Better at Detecting Functional Decline in GA

The metrics could lead to future clinical trials that better characterize both the natural history of the disease as well as early treatment response, the authors suggest.

The World According to GARPED

Study finds GA patients with a reabsorbed PED have significant visual deficits and may not benefit from new treatments aimed at inhibiting the complement system, as the mechanism is different.

cRORA Area on SD-OCT Shows Potential Utility as GA Parameter

The measurement was comparable to that shown on FAF in this study. Dispersion pattern and baseline lesion size may also predict enlargement rate.

Upcoming Events

February 28, 2024

The Anti-evaporative Piece of the Dry Eye Rx Eye Drop Puzzle
Location: Morton's The Steakhouse
Presenter: Paul M. Karpecki, OD
: 7:00pm ET

Sponsored by Bausch + Lomb

Register here

February 29, 2024

Showcasing Inflammation and IOP Control
Location: Ruth's Chris Steak House
Presenter: Michael Chaglasian, OD
: 7:15pm ET

Sponsored by Bausch + Lomb

Register here

March 6, 2024

Addressing a Major Gap in the Treatment of Dry Eye Disease
Location: Virtual
Presenters:  Jennifer Loh, MD, and Damon Dierker, OD
Webinar: 7:00pm ET

Sponsored by Bausch + Lomb

Register here